U.S. market Closed. Opens in 9 minutes

ALXO | ALX Oncology Holdings Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/A1.18M4.80M2.07M
Cost of Revenue836.00K1.47M736.00K1.07M4.36M1.88M
Gross Profit-836.00K-1.47M-736.00K107.00K436.00K187.00K
Operating Expenses169.89M127.44M83.56M43.77M19.62M13.87M
Selling, General & Admin28.48M29.04M23.39M14.81M3.31M2.60M
Research & Development141.79M98.40M60.17M28.96M16.31M11.27M
Other Operating ExpensesN/A-260.00K84.00K-404.00K-5.00K-2.00K
Operating Income-170.28M-127.44M-83.56M-43.66M-19.18M-13.68M
Other Expenses / Income9.47M4.02M71.00K-1.84M-26.00K-2.00K
Before Tax Income-160.81M-123.42M-83.48M-45.50M-19.21M-13.69M
Income Tax ExpensesN/A64.00K-21.00K241.00K34.00K45.00K
Net Income-160.81M-123.48M-83.46M-45.74M-19.24M-13.73M
Interest Expenses1.56M-4.36M13.00K811.00K21.00KN/A
Basic Shares Outstanding42.99M40.70M40.31M39.84M36.49M21.95M
Diluted Shares Outstanding42.99M40.70M40.31M39.84M36.49M21.95M
EBITDA-169.44M-127.44M-83.47M-44.07M-18.76M-13.26M
EBITDA Margin0.00%0.00%0.00%-3,728.17%-391.14%-641.27%
EBIT-159.24M-127.78M-83.47M-44.69M-19.19M-13.69M
EBIT Margin0.00%0.00%0.00%-3,780.71%-400.08%-662.12%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙